{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:51:50Z","timestamp":1793224310867,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004772","name":"Ningxia Natural Science Foundation","doi-asserted-by":"crossref","award":["2022AAC02065,2024AAC03701"],"award-info":[{"award-number":["2022AAC02065,2024AAC03701"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08468-5","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:07:20Z","timestamp":1781885240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ENO1 interacts with PKM to promote HBV-related hepatocellular carcinoma progression and HBV replication"],"prefix":"10.1186","volume":"24","author":[{"given":"Yan-chao","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-ying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-min","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Na","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Chun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"5","key":"8468_CR1","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/ijc.34045","volume":"151","author":"S Chen","year":"2022","unstructured":"Chen S, Gao Y, Wang Y, Daemen T. The combined signatures of hypoxia and cellular landscape provides a prognostic and therapeutic biomarker in hepatitis B virus-related hepatocellular carcinoma. Int J Cancer. 2022;151(5):809\u201324.","journal-title":"Int J Cancer"},{"key":"8468_CR2","doi-asserted-by":"publisher","first-page":"965548","DOI":"10.3389\/fimmu.2022.965548","volume":"13","author":"E Tourkochristou","year":"2022","unstructured":"Tourkochristou E, Assimakopoulos SF, Thomopoulos K, Marangos M, Triantos C. NAFLD and HBV interplay - related mechanisms underlying liver disease progression. Front Immunol. 2022;13:965548.","journal-title":"Front Immunol"},{"issue":"1","key":"8468_CR3","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1080\/22221751.2021.2006580","volume":"10","author":"A Kostyusheva","year":"2021","unstructured":"Kostyusheva A, Brezgin S, Glebe D, Kostyushev D, Chulanov V. Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification. Emerg microbes infections. 2021;10(1):2264\u201375.","journal-title":"Emerg microbes infections"},{"key":"8468_CR4","doi-asserted-by":"crossref","unstructured":"Mahmood F, Xu R, Awan MUN, Song Y, Han Q, Xia X et al. HBV vaccines: advances and development. Vaccines. 2023;11(12):1862.","DOI":"10.3390\/vaccines11121862"},{"issue":"11","key":"8468_CR5","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1111\/jgh.16340","volume":"38","author":"H Wang","year":"2023","unstructured":"Wang H, Zhang J. The glucose metabolic reprogramming in hepatitis B virus infection and hepatitis B virus associated diseases. J Gastroenterol Hepatol. 2023;38(11):1886\u201391.","journal-title":"J Gastroenterol Hepatol"},{"key":"8468_CR6","doi-asserted-by":"crossref","unstructured":"Lan W, Wang Y, Zhou Z, Sun X, Zhang Y, Zhang F. Metabolic regulation of hepatitis B virus infection in HBV-transgenic mice. Metabolites. 2022;12(4):287.","DOI":"10.3390\/metabo12040287"},{"issue":"12","key":"8468_CR7","doi-asserted-by":"publisher","first-page":"e29298","DOI":"10.1002\/jmv.29298","volume":"95","author":"A Nuermaimaiti","year":"2023","unstructured":"Nuermaimaiti A, Chang L, Yan Y, Sun H, Xiao Y, Song S, et al. The role of sex hormones and receptors in HBV infection and development of HBV-related HCC. J Med Virol. 2023;95(12):e29298.","journal-title":"J Med Virol"},{"key":"8468_CR8","doi-asserted-by":"publisher","first-page":"149536","DOI":"10.1016\/j.bbrc.2024.149536","volume":"698","author":"C Li","year":"2024","unstructured":"Li C, Liang G, Yan K, Wang Y. NRF2 mutation enhances the immune escape of hepatocellular carcinoma by reducing STING activation. Biochem Biophys Res Commun. 2024;698:149536.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"8468_CR9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jhep.2022.11.017","volume":"78","author":"J Sun","year":"2023","unstructured":"Sun J, Ding J, Shen Q, Wang X, Wang M, Huang Y, et al. Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma. J Hepatol. 2023;78(3):627\u201342.","journal-title":"J Hepatol"},{"key":"8468_CR10","volume-title":"Metabolic reprogramming and cancer progression","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Volume 368. New York, NY: Science; 2020. 6487."},{"issue":"2","key":"8468_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","volume":"12","author":"D Du","year":"2022","unstructured":"Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, et al. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm Sinica B. 2022;12(2):558\u201380.","journal-title":"Acta Pharm Sinica B"},{"key":"8468_CR12","doi-asserted-by":"crossref","unstructured":"Foglia B, Beltr\u00e0 M, Sutti S, Cannito S. Metabolic reprogramming of HCC: a new microenvironment for immune responses. Int J Mol Sci. 2023;24(8):7463.","DOI":"10.3390\/ijms24087463"},{"issue":"5","key":"8468_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41419-024-06743-1","volume":"15","author":"J Luo","year":"2024","unstructured":"Luo J, Yang Y, Zhang G, Fang D, Liu K, Mei Y, et al. Energy stress-induced circDDX21 promotes glycolysis and facilitates hepatocellular carcinogenesis. Cell Death Dis. 2024;15(5):354.","journal-title":"Cell Death Dis"},{"key":"8468_CR14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.omto.2021.12.026","volume":"24","author":"CK Huang","year":"2022","unstructured":"Huang CK, Sun Y, Lv L, Ping Y. ENO1 and Cancer. Mol therapy oncolytics. 2022;24:288\u201398.","journal-title":"Mol therapy oncolytics"},{"key":"8468_CR15","doi-asserted-by":"crossref","unstructured":"Li Y, Zhang S, Li Y, Liu J, Li Q, Zang W et al. The regulatory network of hnRNPs underlying regulating PKM alternative splicing in tumor progression. Biomolecules. 2024;14(5):1025.","DOI":"10.3390\/biom14050566"},{"issue":"1","key":"8468_CR16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1186\/s12967-024-05847-8","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, Liu L, Li B. Role of ENO1 and its targeted therapy in tumors. J translational Med. 2024;22(1):1025.","journal-title":"J translational Med"},{"issue":"15","key":"8468_CR17","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1158\/0008-5472.CAN-20-3543","volume":"81","author":"HJ Li","year":"2021","unstructured":"Li HJ, Ke FY, Lin CC, Lu MY, Kuo YH, Wang YP, et al. ENO1 Promotes Lung Cancer Metastasis via HGFR and WNT Signaling-Driven Epithelial-to-Mesenchymal Transition. Cancer Res. 2021;81(15):4094\u2013109.","journal-title":"Cancer Res"},{"key":"8468_CR18","doi-asserted-by":"crossref","unstructured":"Lin Y, Zhang W, Liu L, Li W, Li Y, Li B. ENO1 Promotes OSCC migration and invasion by orchestrating IL-6 Secretion from macrophages via a positive feedback loop. Int J Mol Sci. 2023;24(1):737.","DOI":"10.3390\/ijms24010737"},{"issue":"3","key":"8468_CR19","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1111\/jcmm.14763","volume":"24","author":"R Chen","year":"2020","unstructured":"Chen R, Li D, Zheng M, Chen B, Wei T, Wang Y, et al. FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K\/Akt pathway via ENO1. J Cell Mol Med. 2020;24(3):2123\u201334.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"8468_CR20","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.yexcr.2015.05.020","volume":"335","author":"X Zhu","year":"2015","unstructured":"Zhu X, Miao X, Wu Y, Li C, Guo Y, Liu Y, et al. ENO1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) in Non-Hodgkin\u2019s Lymphomas. Exp Cell Res. 2015;335(2):216\u201323.","journal-title":"Exp Cell Res"},{"issue":"12","key":"8468_CR21","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1038\/s41589-023-01391-6","volume":"19","author":"L Sun","year":"2023","unstructured":"Sun L, Suo C, Zhang T, Shen S, Gu X, Qiu S, et al. ENO1 promotes liver carcinogenesis through YAP1-dependent arachidonic acid metabolism. Nat Chem Biol. 2023;19(12):1492\u2013503.","journal-title":"Nat Chem Biol"},{"issue":"9","key":"8468_CR22","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/kjm2.12720","volume":"39","author":"C Tang","year":"2023","unstructured":"Tang C, Zhang H, Deng WS, Xiong LQ, Zhou LQ. Role of POU1F1 promoting the properties of stemness of gastric carcinoma through ENO1-mediated glycolysis reprogramming. Kaohsiung J Med Sci. 2023;39(9):904\u201315.","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"8468_CR23","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41598-022-05408-3","volume":"12","author":"L Romero-Ram\u00edrez","year":"2022","unstructured":"Romero-Ram\u00edrez L, Garc\u00eda-Rama C, Wu S, Mey J. Bile acids attenuate PKM2 pathway activation in proinflammatory microglia. Sci Rep. 2022;12(1):1459.","journal-title":"Sci Rep"},{"issue":"5","key":"8468_CR24","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1158\/0008-5472.CAN-20-0948","volume":"82","author":"WK Ma","year":"2022","unstructured":"Ma WK, Voss DM, Scharner J, Costa ASH, Lin KT, Jeon HY, et al. ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth. Cancer Res. 2022;82(5):900\u201315.","journal-title":"Cancer Res"},{"key":"8468_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semcdb.2015.08.004","volume":"43","author":"WJ Israelsen","year":"2015","unstructured":"Israelsen WJ, Vander Heiden MG. Pyruvate kinase: Function, regulation and role in cancer. Semin Cell Dev Biol. 2015;43:43\u201351.","journal-title":"Semin Cell Dev Biol"},{"issue":"9","key":"8468_CR26","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1242\/jcs.114.9.1655","volume":"128","author":"W Yang","year":"2015","unstructured":"Yang W, Lu Z. Pyruvate kinase M2 at a glance. J Cell Sci. 2015;128(9):1655\u201360.","journal-title":"J Cell Sci"},{"key":"8468_CR27","doi-asserted-by":"publisher","first-page":"102458","DOI":"10.1016\/j.redox.2022.102458","volume":"56","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Yin Y, Yu M, Gao D, Sun J, Yang Z, et al. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism. Redox Biol. 2022;56:102458.","journal-title":"Redox Biol"},{"issue":"1","key":"8468_CR28","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1186\/s12967-024-05668-9","volume":"22","author":"S Rong","year":"2024","unstructured":"Rong S, Dai B, Yang C, Lan Z, Wang L, Xu L, et al. HNRNPC modulates PKM alternative splicing via m6A methylation, upregulating PKM2 expression to promote aerobic glycolysis in papillary thyroid carcinoma and drive malignant progression. J translational Med. 2024;22(1):914.","journal-title":"J translational Med"},{"key":"8468_CR29","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Maga\u00f1a A, Blanco FJ, Human PCNA structure, function and interactions. 2020;10(4):570.","DOI":"10.3390\/biom10040570"},{"issue":"23","key":"8468_CR30","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.21037\/atm-21-6133","volume":"9","author":"R Liu","year":"2021","unstructured":"Liu R, Sun K, Wang Y, Jiang Y, Kang J, Ma H. The effects of proliferating cell nuclear antigen and p53 in patients with oral squamous cell carcinoma: a systematic review and meta-analysis. Annals translational Med. 2021;9(23):1739.","journal-title":"Annals translational Med"},{"key":"8468_CR31","doi-asserted-by":"publisher","first-page":"215609","DOI":"10.1016\/j.canlet.2022.215609","volume":"534","author":"Y Sun","year":"2022","unstructured":"Sun Y, Sun H, Qi Y, Pan M, An N, Leng X, et al. Ring finger protein 6 enhances chemo-resistance by transcriptionally activating proliferating cell nuclear antigen expression and attenuating DNA damage in lung adenocarcinoma. Cancer Lett. 2022;534:215609.","journal-title":"Cancer Lett"},{"key":"8468_CR32","first-page":"209","volume":"100","author":"CK S\u00f8gaard","year":"2024","unstructured":"S\u00f8gaard CK, Otterlei M. Targeting proliferating cell nuclear antigen (PCNA) for cancer therapy. Advances in pharmacology (San Diego. Calif). 2024;100:209\u201346.","journal-title":"Calif)"},{"key":"8468_CR33","doi-asserted-by":"crossref","unstructured":"Kwan A, McDermott-Brown I, Muthana M. Proliferating Cell Nuclear Antigen in the Era of Oncolytic Virotherapy. Viruses. 2024;16(8):1264.","DOI":"10.3390\/v16081264"},{"issue":"7","key":"8468_CR34","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1097\/CM9.0000000000001192","volume":"134","author":"DD Li","year":"2020","unstructured":"Li DD, Zhang JW, Zhang R, Xie JH, Zhang K, Lin GG, et al. Proliferating cell nuclear antigen (PCNA) overexpression in hepatocellular carcinoma predicts poor prognosis as determined by bioinformatic analysis. Chin Med J. 2020;134(7):848\u201350.","journal-title":"Chin Med J"},{"key":"8468_CR35","doi-asserted-by":"publisher","first-page":"217002","DOI":"10.1016\/j.canlet.2024.217002","volume":"595","author":"C Shen","year":"2024","unstructured":"Shen C, Liu J, Xie F, Yu Y, Ma X, Hu D, et al. N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination. Cancer Lett. 2024;595:217002.","journal-title":"Cancer Lett"},{"issue":"7","key":"8468_CR36","doi-asserted-by":"publisher","first-page":"e24406","DOI":"10.1002\/jcla.24406","volume":"36","author":"Z Li","year":"2022","unstructured":"Li Z, Jin Q, Sun Y. LINC00941 promoted in vitro progression and glycolysis of laryngocarcinoma by upregulating PKM via activating the PI3K\/AKT\/mTOR signaling pathway. J Clin Lab Anal. 2022;36(7):e24406.","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"8468_CR37","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/mc.22946","volume":"58","author":"K Pant","year":"2019","unstructured":"Pant K, Mishra AK, Pradhan SM, Nayak B, Das P, Shalimar D, et al. Butyrate inhibits HBV replication and HBV-induced hepatoma cell proliferation via modulating SIRT-1\/Ac-p53 regulatory axis. Mol Carcinog. 2019;58(4):524\u201332.","journal-title":"Mol Carcinog"},{"issue":"7","key":"8468_CR38","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1007\/s12094-023-03114-8","volume":"25","author":"CK Huang","year":"2023","unstructured":"Huang CK, Lv L, Chen H, Sun Y, Ping Y. ENO1 promotes immunosuppression and tumor growth in pancreatic cancer. Clin translational oncology: official publication Federation Span Oncol Soc Natl Cancer Inst Mexico. 2023;25(7):2250\u201364.","journal-title":"Clin translational oncology: official publication Federation Span Oncol Soc Natl Cancer Inst Mexico"},{"issue":"12","key":"8468_CR39","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.15252\/embr.201643300","volume":"17","author":"TL Dayton","year":"2016","unstructured":"Dayton TL, Jacks T, Vander Heiden MG. PKM2, cancer metabolism, and the road ahead. EMBO Rep. 2016;17(12):1721\u201330.","journal-title":"EMBO Rep"},{"key":"8468_CR40","first-page":"117822342412856","volume":"18","author":"A Giannoudis","year":"2024","unstructured":"Giannoudis A, Heath A, Sharma V. ENO1 as a Biomarker of Breast Cancer Progression and Metastasis: A Bioinformatic Approach Using Available Databases. Breast cancer: basic Clin Res. 2024;18:11782234241285648.","journal-title":"Breast cancer: basic Clin Res"},{"issue":"2","key":"8468_CR41","doi-asserted-by":"publisher","first-page":"585","DOI":"10.21037\/jgo-23-151","volume":"14","author":"N Wang","year":"2023","unstructured":"Wang N, Qiao H, Hao J, Deng C, Zhou N, Yang L, et al. RNA-binding protein ENO1 promotes the tumor progression of gastric cancer by binding to and regulating gastric cancer-related genes. J Gastrointest Oncol. 2023;14(2):585\u201398.","journal-title":"J Gastrointest Oncol"},{"issue":"9","key":"8468_CR42","first-page":"628","volume":"42","author":"C Ma","year":"2019","unstructured":"Ma C, Zu X, Liu K, Bode AM, Dong Z, Liu Z, et al. Knockdown of Pyruvate Kinase M Inhibits Cell Growth and Migration by Reducing NF-kB Activity in Triple-Negative Breast Cancer Cells. Mol Cells. 2019;42(9):628\u201336.","journal-title":"Mol Cells"},{"issue":"1","key":"8468_CR43","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s11658-024-00622-5","volume":"29","author":"A Wang","year":"2024","unstructured":"Wang A, Zeng Y, Zhang W, Zhao J, Gao L, Li J, et al. N(6)-methyladenosine-modified SRPK1 promotes aerobic glycolysis of lung adenocarcinoma via PKM splicing. Cell Mol Biol Lett. 2024;29(1):106.","journal-title":"Cell Mol Biol Lett"},{"issue":"19","key":"8468_CR44","doi-asserted-by":"publisher","first-page":"8558","DOI":"10.7150\/thno.44873","volume":"10","author":"D Chen","year":"2020","unstructured":"Chen D, Wang Y, Lu R, Jiang X, Chen X, Meng N, et al. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing. Theranostics. 2020;10(19):8558\u201372.","journal-title":"Theranostics"},{"issue":"4","key":"8468_CR45","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2174\/1568009620666200115162814","volume":"20","author":"M Cardano","year":"2020","unstructured":"Cardano M, Tribioli C, Prosperi E. Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation. Curr Cancer Drug Targets. 2020;20(4):240\u201352.","journal-title":"Curr Cancer Drug Targets"},{"issue":"24","key":"8468_CR46","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.1111\/febs.15276","volume":"287","author":"H Cheng","year":"2020","unstructured":"Cheng H, Cao X, Min X, Zhang X, Kong Q, Mao Q, et al. Heat-Shock protein A12A is a novel PCNA-binding protein and promotes hepatocellular carcinoma growth. FEBS J. 2020;287(24):5464\u201377.","journal-title":"FEBS J"},{"issue":"1","key":"8468_CR47","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/s41467-021-21850-9","volume":"12","author":"L Wei","year":"2021","unstructured":"Wei L, Ploss A. Hepatitis B virus cccDNA is formed through distinct repair processes of each strand. Nat Commun. 2021;12(1):1591.","journal-title":"Nat Commun"},{"issue":"5","key":"8468_CR48","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1097\/HEP.0000000000000455","volume":"78","author":"F Yang","year":"2023","unstructured":"Yang F, Hilakivi-Clarke L, Shaha A, Wang Y, Wang X, Deng Y, et al. Metabolic reprogramming and its clinical implication for liver cancer. Hepatology (Baltimore MD). 2023;78(5):1602\u201324.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"6","key":"8468_CR49","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.cmet.2023.03.017","volume":"35","author":"Q Li","year":"2023","unstructured":"Li Q, Zhang L, Yang Q, Li M, Pan X, Xu J, et al. Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners. Cell Metabol. 2023;35(6):912\u2013. \u2013\u200927.e7.","journal-title":"Cell Metabol"},{"issue":"1","key":"8468_CR50","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21(1):14.","journal-title":"Mol Cancer"},{"issue":"5","key":"8468_CR51","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.gendis.2022.10.006","volume":"10","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Peng Q, Zheng J, Yang Y, Zhang X, Ma A, et al. The function and mechanism of lactate and lactylation in tumor metabolism and microenvironment. Genes Dis. 2023;10(5):2029\u201337.","journal-title":"Genes Dis"},{"issue":"1","key":"8468_CR52","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s41420-023-01719-0","volume":"9","author":"Q Yang","year":"2023","unstructured":"Yang Q, Meng X, Chen J, Li X, Huang Y, Xiao X, et al. RPLP2 activates TLR4 in an autocrine manner and promotes HIF-1\u03b1-induced metabolic reprogramming in hepatocellular carcinoma. Cell death discovery. 2023;9(1):440.","journal-title":"Cell death discovery"},{"issue":"6","key":"8468_CR53","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1039\/D3MD00128H","volume":"14","author":"Y Zou","year":"2023","unstructured":"Zou Y, Lu N, Yang X, Xie Z, Lei X, Liu X, et al. Synthesis and anti-hepatocellular carcinoma evaluation of salicylic acid-modified indole trimethoxy flavonoid derivatives. RSC Med Chem. 2023;14(6):1172\u201385.","journal-title":"RSC Med Chem"},{"issue":"10","key":"8468_CR54","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1111\/febs.16326","volume":"289","author":"H Xiong","year":"2022","unstructured":"Xiong H, Chen Z, Zhao J, Li W, Zhang S. TNF-\u03b1\/ENO1 signaling facilitates testicular phagocytosis by directly activating Elmo1 gene expression in mouse Sertoli cells. FEBS J. 2022;289(10):2809\u201327.","journal-title":"FEBS J"},{"key":"8468_CR55","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bbrc.2021.09.027","volume":"578","author":"JY Hou","year":"2021","unstructured":"Hou JY, Cao J, Gao LJ, Zhang FP, Shen J, Zhou L, et al. Upregulation of \u03b1 enolase (ENO1) crotonylation in colorectal cancer and its promoting effect on cancer cell metastasis. Biochem Biophys Res Commun. 2021;578:77\u201383.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"8468_CR56","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/mec.16817","volume":"32","author":"Z Tian","year":"2023","unstructured":"Tian Z, Zhu L, Michaud JP, Zha M, Cheng J, Shen Z, et al. Metabolic reprogramming of Helicoverpa armigera larvae by HearNPV facilitates viral replication and host immune suppression. Mol Ecol. 2023;32(5):1169\u201382.","journal-title":"Mol Ecol"},{"issue":"1","key":"8468_CR57","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.virs.2023.11.010","volume":"39","author":"X Meng","year":"2024","unstructured":"Meng X, Zhu Y, Yang W, Zhang J, Jin W, Tian R, et al. HIF-1\u03b1 promotes virus replication and cytokine storm in H1N1 virus-induced severe pneumonia through cellular metabolic reprogramming. Virol Sin. 2024;39(1):81\u201396.","journal-title":"Virol Sin"},{"issue":"1","key":"8468_CR58","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s43556-024-00229-4","volume":"5","author":"Y Hu","year":"2024","unstructured":"Hu Y, Liu W, Fang W, Dong Y, Zhang H, Luo Q. Tumor energy metabolism: implications for therapeutic targets. Mol Biomed. 2024;5(1):63.","journal-title":"Mol Biomed"},{"issue":"1","key":"8468_CR59","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","volume":"23","author":"M Tufail","year":"2024","unstructured":"Tufail M, Jiang CH, Li N. Altered metabolism in cancer: insights into energy pathways and therapeutic targets. Mol Cancer. 2024;23(1):203.","journal-title":"Mol Cancer"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08468-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08468-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08468-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:04:14Z","timestamp":1788782654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08468-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8468"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08468-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted following ethical approval from the General Hospital of Ningxia Medical University.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1144"}}